BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH MEDSANTEK TO EXPAND ACCESS TO PORTFOLIO ACROSS TURKEY
Bio-Techne (NASDAQ: TECH) has announced a new distribution partnership with MedSanTek to expand its product reach across Turkey and Azerbaijan. The agreement enables MedSanTek to distribute Bio-Techne's portfolio of brands including R&D Systems, Novus, Tocris, Protein Simple, Advanced Cell Diagnostics, and Asuragen.
MedSanTek, founded in the late 2000s, is a leading in vitro diagnostics and research products distributor in the region, specializing in molecular biology, immunology, cancer research, and cell therapy. The partnership aims to leverage MedSanTek's local market expertise and distribution network to enhance Bio-Techne's presence in Turkey and Azerbaijan's biotechnology, laboratory, and hospital sectors.
Bio-Techne (NASDAQ: TECH) ha annunciato una nuova partnership di distribuzione con MedSanTek per espandere la propria portata di prodotti in Turchia e Azerbaigian. L'accordo consente a MedSanTek di distribuire il portafoglio di marchi di Bio-Techne, tra cui R&D Systems, Novus, Tocris, Protein Simple, Advanced Cell Diagnostics e Asuragen.
MedSanTek, fondata alla fine degli anni 2000, è un distributore leader di prodotti per la diagnostica in vitro e la ricerca nella regione, specializzandosi in biologia molecolare, immunologia, ricerca sul cancro e terapia cellulare. La partnership mira a sfruttare l'esperienza di mercato locale di MedSanTek e la rete di distribuzione per migliorare la presenza di Bio-Techne nei settori biotecnologico, laboratoristico e ospedaliero della Turchia e dell'Azerbaigian.
Bio-Techne (NASDAQ: TECH) ha anunciado una nueva asociación de distribución con MedSanTek para expandir su alcance de productos en Turquía y Azerbaiyán. El acuerdo permite a MedSanTek distribuir el portafolio de marcas de Bio-Techne, que incluye R&D Systems, Novus, Tocris, Protein Simple, Advanced Cell Diagnostics y Asuragen.
MedSanTek, fundada a finales de la década de 2000, es un distribuidor líder de productos de diagnóstico in vitro e investigación en la región, especializándose en biología molecular, inmunología, investigación del cáncer y terapia celular. La asociación tiene como objetivo aprovechar la experiencia de MedSanTek en el mercado local y su red de distribución para mejorar la presencia de Bio-Techne en los sectores de biotecnología, laboratorios y hospitales de Turquía y Azerbaiyán.
Bio-Techne (NASDAQ: TECH)는 MedSanTek와의 새로운 유통 파트너십을 발표하여 터키와 아제르바이잔에서의 제품 범위를 확장합니다. 이번 합의에 따라 MedSanTek은 R&D Systems, Novus, Tocris, Protein Simple, Advanced Cell Diagnostics 및 Asuragen을 포함한 Bio-Techne의 브랜드 포트폴리오를 배급합니다.
MedSanTek은 2000년대 후반에 설립된 지역의 이끌어가는 인체 외 진단 및 연구 제품 유통업체로, 분자 생물학, 면역학, 암 연구 및 세포 치료 전문입니다. 이 파트너십은 MedSanTek의 지역 시장 전문 지식과 유통 네트워크를 활용하여 터키와 아제르바이잔의 생명공학, 실험실 및 병원 부문에서 Bio-Techne의 존재를 강화하는 것을 목표로 합니다.
Bio-Techne (NASDAQ: TECH) a annoncé un nouveau partenariat de distribution avec MedSanTek pour étendre sa portée de produits en Turquie et en Azerbaïdjan. L'accord permet à MedSanTek de distribuer le portefeuille de marques de Bio-Techne, y compris R&D Systems, Novus, Tocris, Protein Simple, Advanced Cell Diagnostics et Asuragen.
MedSanTek, fondée à la fin des années 2000, est un distributeur leader dans le domaine du diagnostic in vitro et des produits de recherche dans la région, se spécialisant en biologie moléculaire, immunologie, recherche sur le cancer et thérapie cellulaire. Ce partenariat vise à tirer parti de l'expertise locale de MedSanTek et de son réseau de distribution pour améliorer la présence de Bio-Techne dans les secteurs de la biotechnologie, des laboratoires et des hôpitaux en Turquie et en Azerbaïdjan.
Bio-Techne (NASDAQ: TECH) hat eine neue Vertriebspartnerschaft mit MedSanTek angekündigt, um die Produktreichweite in der Türkei und Aserbaidschan zu erweitern. Die Vereinbarung ermöglicht es MedSanTek, das Portfolio von Bio-Techne, einschließlich R&D Systems, Novus, Tocris, Protein Simple, Advanced Cell Diagnostics und Asuragen, zu vertreiben.
MedSanTek, gegründet Ende der 2000er Jahre, ist ein führender Distributor von In-vitro-Diagnose- und Forschungsprodukten in der Region, der sich auf Molekularbiologie, Immunologie, Krebsforschung und Zelltherapie spezialisiert hat. Die Partnerschaft zielt darauf ab, die lokale Marktexpertise und das Vertriebsnetz von MedSanTek zu nutzen, um die Präsenz von Bio-Techne in den Biotechnologie-, Labor- und Krankenhaussektoren der Türkei und Aserbaidschan zu verbessern.
- Strategic expansion into Turkey and Azerbaijan markets through established local distributor
- Access to new customer base including biotechs, labs, and hospitals in the region
- Distribution agreement covers multiple Bio-Techne brands, maximizing market penetration
- None.
Insights
This distribution agreement marks a strategic expansion into Turkey and Azerbaijan's growing life sciences markets. The partnership with MedSanTek, an established regional distributor, provides Bio-Techne with immediate access to a network of biotechs, laboratories and hospitals across major cities. Turkey's healthcare and biotech sectors have shown significant growth potential, with increasing R&D investments and a developing biotechnology infrastructure.
The deal encompasses Bio-Techne's complete portfolio including R&D Systems, Novus, Tocris, Protein Simple, Advanced Cell Diagnostics and Asuragen brands. This comprehensive offering positions Bio-Techne to capture market share in molecular biology, immunology and cancer research segments. While the financial terms aren't disclosed, the partnership should contribute to revenue growth through increased market penetration in these emerging markets.
Founded in the late 2000s, MedSanTek is a leading in vitro diagnostics and research products distributor, serving
"As MedSanTek's founder, I'm thrilled to partner with Bio-Techne to bring their world-class products—antibodies, proteins, assays, and diagnostic kits—to
"We are excited to partner with MedSanTek to expand the reach of our products and services in the important
For more information about Bio-Techne and its range of products and services, visit our Website.
About Bio-Techne
Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With hundreds of thousands of products in its portfolio, Bio-Techne generated approximately
About Bio-Techne Corporation (NASDAQ: TECH)
Contact: David Clair, Vice President, Investor Relations & Corporate Development
david.clair@bio-techne.com
612-656-4416
Medsantek Life Sciences Contact
View original content to download multimedia:https://www.prnewswire.com/news-releases/bio-techne-announces-new-distribution-agreement-with-medsantek-to-expand-access-to-portfolio-across-turkey-302329354.html
SOURCE Bio-Techne Corporation
FAQ
What brands will MedSanTek distribute for Bio-Techne (TECH) in Turkey?
Which markets will Bio-Techne (TECH) expand into through the MedSanTek partnership?
What types of products will Bio-Techne (TECH) distribute through MedSanTek?
When did Bio-Techne (TECH) announce its distribution agreement with MedSanTek?
